DOES ADD-ON EVENING DOSE OF FORMOTEROL IMPROVE LUNG FUNCTION FOR COPD PATIENTS RECEIVING FIXED-DOSE OF TIOTROPIUM AND FORMOTEROL?

被引：0
|
作者：
Imran, M. [1 ]
Kotwani, A. [1 ]
Chhabra, S. [1 ]
Vijayan, V. [1 ]
机构：
[1] VP Chest Inst, Delhi, India
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)73665-2
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A120 / A120
页数：1
相关论文
共 50 条
  • [41] Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD
    François Maltais
    Alan Hamilton
    Florian Voß
    M. Reza Maleki-Yazdi
    Advances in Therapy, 2019, 36 : 962 - 968
  • [42] Dose Determination for a Fixed-Dose Drug Combination: A Phase II Randomized Controlled Trial for Tiotropium/Olodaterol Versus Tiotropium in Patients with COPD
    Maltais, Francois
    Hamilton, Alan
    Voss, Florian
    Maleki-Yazdi, M. Reza
    ADVANCES IN THERAPY, 2019, 36 (04) : 962 - 968
  • [43] Long-Term Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate In Patients With Moderate To Severe COPD: The Augment COPD Extension Trial
    Rennard, S. I.
    D'Urzo, A. D.
    Donohue, J. F.
    He, T.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [44] The Efficacy And Safety Of Aclidinium/formoterol Fixed-Dose Combination Compared With Salmeterol/fluticasone In Patients With COPD: Results From A Phase Iii Study
    Vogelmeier, C.
    Paggiaro, P.
    Dorca, J.
    Sliwinski, P.
    Mallet, M.
    Kirsten, A. -M.
    Seoane, B.
    Segarra, R.
    Leselbaum, A.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [45] Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In Patients With Moderate To Severe COPD, Stratified By Inhaled Corticosteroid Use
    Bateman, E. D.
    Chapman, K. R.
    Rennard, S. I.
    Lakkis, H.
    Moya, M.
    Garcia Gil, E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [46] Ceiling effect of beclomethasone/formoterol/glycopyrronium triple fixed-dose combination in COPD: A translational bench-to-bedside study
    Rogliani, Paola
    Ora, Josuel
    Girolami, Andrea
    Rossi, Immacolata
    de Guido, Ilaria
    Facciolo, Francesco
    Cazzola, Mario
    Calzetta, Luigino
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2021, 69
  • [47] Bronchodilator efficacy of tiotropium formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD
    Salvi, Sundeep
    Brashier, Bill
    Gothi, Dipti
    Karkhanis, Vinaya
    Madas, Sapna
    Gogtay, Jaideep
    Joshi, Jyotsna
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2014, 27 (01) : 90 - 95
  • [48] Pharmacokinetic/Pharmacodynamic Interactions Between Extrafine Beclomethasone Dipropionate and Formoterol Fumarate Components of a Fixed-Dose Combination for Asthma and COPD
    Georges, G.
    Lucardie, A.
    Garofalo, C.
    Beaudot, C.
    Cella, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [49] THE FIXED-DOSE COMBINATION OF TIOTROPIUM plus OLODATEROL HAS A RAPID ONSET OF ACTION IN PATIENTS WITH COPD
    Veale, A.
    Ferguson, G.
    Pizzichini, E.
    Flezar, M.
    Groenke, L.
    Korducki, L.
    RESPIROLOGY, 2016, 21 : 129 - 129
  • [50] The fixed-dose combination of tiotropium plus olodaterol has a rapid onset of action in patients with COPD
    Ferguson, Gary T.
    Pizzichini, Emilio
    Flezar, Matjaz
    Groenke, Lars
    Korducki, Lawrence
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
12345